Patient Information Leaflet
Donepezilo Flas Viatris Pharmaceuticals 10 mg Buccal Tablets EFG
Donepezil Hydrochloride
Read this leaflet carefully before you start taking this medicine because it contains important information for you.
1.What Donepezilo Flas Viatris Pharmaceuticals is and what it is used for
2.What you need to know before you start taking Donepezilo Flas Viatris Pharmaceuticals
3.How to take Donepezilo Flas Viatris Pharmaceuticals
4.Possible side effects
5.Storage of Donepezilo Flas Viatris Pharmaceuticals
6.Contents of the pack and additional information
Donepezilo Flas Viatris Pharmaceuticals contains the active substance donepezil hydrochloride.
Donepezilo belongsto the group of medicines known as cholinesterase inhibitors.Donepezil hydrochloride increases the levels in the brain of a substance related to memory (acetylcholine) by reducing the rate of breakdown of this substance.
It is used for the treatment of the symptoms of dementia in patients with a diagnosis of Alzheimer's disease, mild to moderately severe.The symptoms of the disease include an increase in memory loss, confusion, and changes in behavior. As a result, patients with Alzheimer's disease have more difficulty performing their daily routine activities.
It is used only in adult patients.
Do not take Donepezilo Flas Viatris Pharmaceuticals:
Warnings and precautions
Consult your doctor or pharmacist before starting to take Donepezilo Flas Viatris Pharmaceuticals,if you suffer or have suffered:
.
Also inform your doctor if you are pregnant or think you may be pregnant.
Children and adolescents
Donepezilo is not recommended for children and adolescents (under 18years).
Other medications and Donepezilo Flas Viatris Pharmaceuticals
Inform your doctor or pharmacist if you are taking, have taken recently or may need to take any other medication. This includes medications you have purchased over the counter at the pharmacy without a doctor's prescription.This also applies to medications you may need to take in the future if you continue to take donepezilo.This is because these medications may decrease or intensify the effects of donepezilo.
Especially,it is essential to inform your doctor or pharmacistif you are taking any of the following types of medications:
If you are to undergo asurgical procedure,in which general anesthesia is required, you must inform your doctorandthe anesthesiologistthat you are takingdonepezilo.This is because the medication may affect the amount of anesthesia needed.
.
Donepezilo may be used in patients with kidney disease or mild to moderate liver disease. Inform your doctor first if you have any kidney or liver disease. Patients with severe liver disease should not take donepezilo.
Inform your doctor or pharmacist of the name of your caregiver. Your caregiver will help you take the medication as prescribed.
Donepezilo Flas Viatris Pharmaceuticals with food, drinks and alcohol
Pregnancy, lactation and fertility
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before using this medication.
Donepezilo should not be used during lactation.
Driving and operating machinery
Alzheimer's disease may affect your ability to drive or operate machinery, so you should not perform these activities unless your doctor tells you that you can.
The medication may also cause fatigue, dizziness and muscle cramps. If you experience any of these effects, you should not drive or operate tools or machinery.
Donepezilo Flas Viatris Pharmaceuticals contains sodium
This medication contains less than 23 mg of sodium (1 mmol) per tablet; this is, essentially “sodium-free”.
How MuchDonepezilo Flas Viatris PharmaceuticalsShould I Take
Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Initially, the recommended dose is 5mg (one white tablet) per day before bedtime. After a month, your doctor may increase the dose to 10mg (one yellow tablet) per day before bedtime.
If you experience abnormal dreams, nightmares, or difficulty sleeping (see section 4), your doctor may recommend taking donepezil in the morning.
The intensity of the dose you will take will change based on the amount of time you have been taking the medication or your doctor's recommendation. The maximum recommended dose is 10mg per night.
Always follow the recommendations of your doctor or pharmacist on how and when to take the medication.
Do not change the dose on your own without your doctor's prior recommendation.
How to Take Donepezilo Flas Viatris Pharmaceuticals
The tablet should be placed on the tongue and allowed to disintegrate before swallowing, with or without water, as preferred.
Use in Children and Adolescents
Donepezilo is not recommended for use in children and adolescents (under 18 years)
If You Take More Donepezilo Flas Viatris Pharmaceuticals Than You Should
If you take more medication than you should, consult your doctor immediately or go to the nearest hospital emergency room, bringing this leaflet and any remaining tablets, or call the Toxicology Information Service, phone 91 562 04 20.
Symptoms of overdose include nausea, vomiting, salivation, sweating, slow heart rate, low blood pressure (dizziness or fainting when standing up), difficulty breathing, loss of consciousness, seizures, and muscle weakness.
If You Forget to Take Donepezilo Flas Viatris Pharmaceuticals
If you forget to take the medication, take the next dose at the usual time. Do not take a double dose to compensate for the missed doses.
If you forget to take your medication for more than a week, before taking the medication again, call your doctor.
If You Interrupt Treatment with Donepezilo Flas Viatris Pharmaceuticals
Do not stop taking the medicationunless your doctor tells you to. If you interrupt treatment with donepezil, the treatment benefits will gradually disappear.
.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
How Long Should I Take Donepezilo Flas Viatris Pharmaceuticals
Your doctor or pharmacist will advise you on how long to continue taking the tablets. You will need to visit your doctor regularly to review your treatment and evaluate your symptoms.
Like all medicines, this medicine may cause side effects, although not everyone will experience them.
The following side effects have been reported by people taking donepezil.
Inform your doctor if you experience any of the following side effectswhile taking donepezil.
Severe side effects
You must inform your doctor immediately if you notice any of the following severe side effects mentioned. You may need urgent medical treatment.
Other side effects:
Frequent side effects (may affect more than 1 in 10 people):
Common side effects (may affect up to 1 in 10 people):
Rare side effects (may affect up to 1 in 1,000 people):
Unknown frequency (cannot be estimated from the available data):
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Vigilance of Medicinal Products for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
This medication does not require special storage conditions.
Do not use this medication after the expiration date that appears on the packaging and on the blister pack after CAD. The expiration date is the last day of the month indicated.
Medications should not be disposed of through drains or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of Donepezilo Flas Viatris Pharmaceuticals
Appearance of the product and contents of the package
Your medicine is presented in the form of buccal dispersible tablets.
Round, flat, bisected tablets with a yellow color, marked with “DL10” on one face and “M” on the other face.
Donepezilo Flas Viatris Pharmaceuticals is presented in blisters of7, 10, 14, 28, 30, 50, 56, 60, 84, 98, 100, 120 and 180buccal dispersible tablets.
Only some package sizes may be commercially available.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder
Viatris Limited
Damastown Industrial Park
Mulhuddart, Dublin 15
Dublin
Ireland
Responsible manufacturer:
Mylan Hungary Kft
H-2900 Komárom
Mylan utca 1
Hungary
or
Mylan UK Healthcare Limited
Building 20, Station Close
Potters Bar, EN6 1TL
United Kingdom
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
Viatris Pharmaceuticals, S.L.U.
C/ General Aranaz, 86
28027 - Madrid
Spain
This medicine is authorized in the member states of the European Economic Area with the following names:
AustriaDonepezil Arcana 10 mg Schemelztabletten
BelgiumDonepezil ODIS Mylan 10 mg
CyprusDonepezil/Generics
SlovakiaDonepezil Mylan 10 mg orodispergovatel’né tablety
SloveniaDonepezil Mylan 10 mg orodisperzibilne tablete
SpainDonepezilo Flas Viatris Pharmaceuticals 10 mg comprimidos bucodispersables EFG
FranceDonepezil Mylan 10 mg comprimé orodispersible
GreeceDonepezil/Mylan
IrelandAripil Orotab 10 mg oro-dispersible tablets
PolandDonegen ODT
PortugalDonepezilo Mylan
United KingdomDonepezil Hydrochloride 10 mg Orodispersible Tablets
Czech RepublicDonepezil Mylan 10 mg tablety dispergovatelné v ústech
RomaniaDonepezil Mylan 10 mg comprimate orodispersabile
SwedenDonepezil Mylan
Last review date of this leaflet:November 2022
More detailed and up-to-date information about this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) https://www.aemps.gob.es/
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.